Position in FHTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,353
+$5,239 QoQ
Shares Held
1,097
+4470.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,724 across 427 Biotechnology names. FHTX ranks #320 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,353 | 1,097 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $114 | 24 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,421 | 1,004 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,489 | 1,736 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,000 | 1,064 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $124 | 34 | Shares | Sole | 2025-11-21 | |
| 2024-12-31 | $12,219 | 2,589 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,458 | 2,842 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $53,912 | 9,376 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $56,685 | 8,448 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $41,931 | 6,501 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $30,970 | 6,194 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,560 | 7,466 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $46,499 | 7,500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $40,823 | 6,399 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $29,558 | 3,445 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $45,056 | 3,313 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $67,042 | 4,402 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $162,788 | 7,118 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $77,269 | 5,547 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $27,613 | 2,588 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,857 | 1,279 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $7,540 | 372 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||